Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Jeppesen, P.
Petersen, L.
Thorup, A.
Abel, M.-B.
Øhlenschlæger, J.
Christensen, T. Ø.
Krarup, G.
Jørgensen, P.
and
Nordentoft, M.
2008.
The association between pre-morbid adjustment, duration of untreated psychosis and outcome in first-episode psychosis.
Psychological Medicine,
Vol. 38,
Issue. 8,
p.
1157.
Carr, Jason A. R.
Norman, Ross M. G.
and
Manchanda, Rahul
2009.
Substance misuse over the first 18 months of specialized intervention for first episode psychosis.
Early Intervention in Psychiatry,
Vol. 3,
Issue. 3,
p.
221.
Mazzoncini, R.
Donoghue, K.
Hart, J.
Morgan, C.
Doody, G. A.
Dazzan, P.
Jones, P. B.
Morgan, K.
Murray, R. M.
and
Fearon, P.
2010.
Illicit substance use and its correlates in first episode psychosis.
Acta Psychiatrica Scandinavica,
Vol. 121,
Issue. 5,
p.
351.
Murphy, Brendan P.
2010.
Beyond the first episode: Candidate factors for a risk prediction model of schizophrenia.
International Review of Psychiatry,
Vol. 22,
Issue. 2,
p.
202.
Omer, Sami
Behan, Caragh
Waddington, John L
and
O'Callaghan, Eadbhard
2010.
Early intervention in psychosis: service models worldwide and the Irish experience.
Irish Journal of Psychological Medicine,
Vol. 27,
Issue. 4,
p.
210.
Simonsen, E.
Friis, S.
Opjordsmoen, S.
Mortensen, E. L.
Haahr, U.
Melle, I.
Joa, I.
Johannessen, J. O.
Larsen, T. K.
Røssberg, J. I.
Rund, B. R.
Vaglum, P.
and
McGlashan, T. H.
2010.
Early identification of non‐remission in first‐episode psychosis in a two‐year outcome study.
Acta Psychiatrica Scandinavica,
Vol. 122,
Issue. 5,
p.
375.
Barnes, Thomas RE
2011.
Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology.
Journal of Psychopharmacology,
Vol. 25,
Issue. 5,
p.
567.
Crespo-Facorro, Benedicto
Pérez-Iglesias, Rocío
Mata, Ignacio
Caseiro, Olalla
Martínez-Garcia, Obdulia
Pardo, Gema
Ramirez-Bonilla, MariLuz
Pelayo-Terán, Jose Maria
and
Vázquez-Barquero, José L.
2011.
Relapse prevention and remission attainment in first-episode non-affective psychosis. A randomized, controlled 1-year follow-up comparison of haloperidol, risperidone and olanzapine.
Journal of Psychiatric Research,
Vol. 45,
Issue. 6,
p.
763.
Alvarez-Jimenez, M.
Priede, A.
Hetrick, S.E.
Bendall, S.
Killackey, E.
Parker, A.G.
McGorry, P.D.
and
Gleeson, J.F.
2012.
Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies.
Schizophrenia Research,
Vol. 139,
Issue. 1-3,
p.
116.
Iniesta, Raquel
Ochoa, Susana
and
Usall, Judith
2012.
Gender Differences in Service Use in a Sample of People with Schizophrenia and Other Psychoses.
Schizophrenia Research and Treatment,
Vol. 2012,
Issue. ,
p.
1.
Caseiro, Olalla
Pérez-Iglesias, Rocío
Mata, Ignacio
Martínez-Garcia, Obdulia
Pelayo-Terán, Jose Maria
Tabares-Seisdedos, Rafael
Ortiz-García de la Foz, Victor
Vázquez-Barquero, José L.
and
Crespo-Facorro, Benedicto
2012.
Predicting relapse after a first episode of non-affective psychosis: A three-year follow-up study.
Journal of Psychiatric Research,
Vol. 46,
Issue. 8,
p.
1099.
Faridi, Kia
Joober, Ridha
and
Malla, Ashok
2012.
Medication adherence mediates the impact of sustained cannabis use on symptom levels in first-episode psychosis.
Schizophrenia Research,
Vol. 141,
Issue. 1,
p.
78.
Mourao-Miranda, J.
Reinders, A. A. T. S.
Rocha-Rego, V.
Lappin, J.
Rondina, J.
Morgan, C.
Morgan, K. D.
Fearon, P.
Jones, P. B.
Doody, G. A.
Murray, R. M.
Kapur, S.
and
Dazzan, P.
2012.
Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study.
Psychological Medicine,
Vol. 42,
Issue. 5,
p.
1037.
Levy, Emmanuelle
Pawliuk, Nicole
Joober, Ridha
Abadi, Sherezad
and
Malla, Ashok
2012.
Medication-Adherent First-Episode Psychosis Patients Also Relapse: Why?.
The Canadian Journal of Psychiatry,
Vol. 57,
Issue. 2,
p.
78.
Ouellet-Plamondon, Clairélaine
and
Abdel-Baki, Amal
2012.
Jeune, urbain… mais psychotique : l’importance du travail de proximité.
Santé mentale au Québec,
Vol. 36,
Issue. 2,
p.
33.
Batalla, Albert
Garcia-Rizo, Clemente
Castellví, Pere
Fernandez-Egea, Emili
Yücel, Murat
Parellada, Eduard
Kirkpatrick, Brian
Martin-Santos, Rocío
and
Bernardo, Miguel
2013.
Screening for substance use disorders in first-episode psychosis: Implications for readmission.
Schizophrenia Research,
Vol. 146,
Issue. 1-3,
p.
125.
Manchanda, Rahul
Chue, Pierre
Malla, Ashok
Tibbo, Phil
Roy, Marc-André
Williams, Richard
Iyer, Srividya
Lutgens, Danyael
and
Banks, Nicola
2013.
Long-Acting Injectable Antipsychotics: Evidence of Effectiveness and Use.
The Canadian Journal of Psychiatry,
Vol. 58,
Issue. 5_suppl,
p.
5.
Tibbo, Phil
Malla, Ashok
Manchanda, Rahul
Williams, Richard
and
Joober, Ridha
2014.
Relapse Risk Assessment in Early Phase Psychosis: The Search for a Reliable and Valid Tool.
The Canadian Journal of Psychiatry,
Vol. 59,
Issue. 12,
p.
655.
Tarricone, Ilaria
Boydell, Jane
Panigada, Serena
Allegri, Fabio
Marcacci, Thomas
Minenna, Maria Gabriella
Kokona, Arnisa
Triolo, Federico
Storbini, Viviana
Michetti, Rossella
Morgan, Craig
Di Forti, Marta
Murray, Robin M.
and
Berardi, Domenico
2014.
The impact of substance use at psychosis onset on First Episode Psychosis course: Results from a 1 year follow-up study in Bologna.
Schizophrenia Research,
Vol. 153,
Issue. 1-3,
p.
60.
Lange, Elisabeth Heffermehl
Nesvåg, Ragnar
Ringen, Petter Andreas
Hartberg, Cecilie Bhandari
Haukvik, Unn Kristin
Andreassen, Ole Andreas
Melle, Ingrid
and
Agartz, Ingrid
2014.
One year follow-up of alcohol and illicit substance use in first-episode psychosis: Does gender matter?.
Comprehensive Psychiatry,
Vol. 55,
Issue. 2,
p.
274.